News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Enzo Biochem (ENZ) Reports Fiscal Second Quarter Results


3/13/2013 6:12:51 AM

Enzo Biochem, Inc. (NYSE:ENZ) today reported results for the fiscal second quarter and six months ended January 31, 2013.

  • Jury declares Life Technologies infringed Enzo Biochem patents and awards Enzo $48.6 million

  • Company Reports Progress on Technology Platforms; Anticipates New Lab-Developed Tests Aimed at Women’s Health Market;

  • Superstorm Sandy Aftermath Interrupts Clinical Labs Top-Line Growth.

  • Read at BioSpace.com


    comments powered by Disqus
       

    ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES